Lupin launches generic anti-depression drug in US
The company "announced the launch of generic paxil CR extended release tablets, 12.5 mg, 25 mg and 37.5 mg, having received an approval from the USFDA earlier
By PTI | Updated:
NEW DELHI: Pharma major Lupin today said it has launched generic paxil drug used for treatment of major depressive order in the US market.
The company "announced today the launch of generic paxil CR extended release tablets, 12.5 mg, 25 mg and 37.5 mg, having received an approval from the United States Food and Drug Administration ( FDA) earlier", Lupin said in a BSE filing.
The drug is used for treatment of major depressive, panic, social anxiety and premenstrual dysphoric disorder, it added.
The stock was trading 0.99 per cent lower at Rs 1,461 on BSE.
The company "announced today the launch of generic paxil CR extended release tablets, 12.5 mg, 25 mg and 37.5 mg, having received an approval from the United States Food and Drug Administration ( FDA) earlier", Lupin said in a BSE filing.
The drug is used for treatment of major depressive, panic, social anxiety and premenstrual dysphoric disorder, it added.
The stock was trading 0.99 per cent lower at Rs 1,461 on BSE.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
